Veru Statistics
NASDAQ: VERUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.42-0.04 (-1.63%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Veru by the numbers
Veru has a market capitalization of $41.3 million based on 17.05M shares outstanding. With trailing EPS of $-0.61, Veru is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.4% below its 50-day average and 3.1% below its 200-day average.
Average daily trading volume is 242.56K shares, or about $586,986 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VERU valuation vs. peer median
| Metric | VERU | Peer median | Difference |
|---|---|---|---|
| Market cap | $41.26M | $41.64M | -1% |
| Avg. volume | 242.56K | 361.71K | -33% |
Peer median across 8 companies: SCYX, NSRX, GRCE, CPHI, IXHL, HOWL, FLNA, LITS.
Valuation
- Market cap
- $41.26M
- EPS (TTM)
- $-0.61
- Shares outstanding
- 17.05M
Price and trading
- Previous close
- 2.46
- Open
- 2.44
- Day range
- 2.39 – 2.52
- 52-week range
- 2.05 – 7.33
- 52-week change
- -43.45%
- Beta
- —
- Volume
- 147.61K
- Average volume
- 242.56K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 10, 2026
Additional statistics
- Market Cap
- 41.26M
- Forward Pe
- -2.64
- Eps
- -0.61
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.33
- Week52 Low
- 2.05
- Avg Volume
- 242.56K
- Shares Outstanding
- 17.05M
- Ma50
- 2.53
- Ma200
- 2.50
- Earnings Date
- Aug 10, 2026
- Pct From52w High
- -66.98%
- Pct From52w Low
- 18.05%